Litcius/Paper detail

Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial

Cristina Tassorelli, Krisztián Nagy, Patricia Pozo‐Rosich, Michel Lantéri‐Minet, Sara Sacco, Tomáš Nežádal, Hua Guo, Rosa De Abreu Ferreira, Giovanna Forero, Joel M. Trugman

2024The Lancet Neurology76 citationsDOI

Topics & Concepts

MedicineTolerabilityMigrainePlaceboClinical endpointPopulationClinical trialRandomized controlled trialAdverse effectPediatricsInternal medicineAlternative medicineEnvironmental healthPathologyMigraine and Headache StudiesTraumatic Brain Injury ResearchNeurological Disorders and Treatments
Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial | Litcius